Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $320.45 million as of April 28, 2026. Its market cap has increased by 71.99% in one year.

Market Cap

320.45M

Enterprise Value

141.69M

1-Year Change

71.99%

Ranking

#3484

Market Cap Chart

Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has increased from $100.46M to $320.45M, an increase of 218.99%. That is a compound annual growth rate of 24.22%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	320.45M	14.28%
Dec 31, 2025	280.40M	-3.25%
Dec 31, 2024	289.83M	3,596.14%
Dec 29, 2023	7.84M	-37.83%
Dec 30, 2022	12.61M	-65.89%
Dec 31, 2021	36.98M	-46.68%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
DiaMedica Therapeutics	341.08M
Bicycle Therapeutics	337.38M
Greenwich LifeSciences	335.42M
Nautilus Biotechnology	331.60M
Cabaletta Bio	328.40M
Surrozen	323.24M
Rezolute	322.00M
NervGen Pharma	317.25M

Market Cap Rankings